Williams Jones & Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Williams Jones & Associates’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,645	Closed	-$663K	–	454
2018 Q1	$663K	Hold	6,645	–	–	0.02%	258
2017 Q4	$623K	Sell	6,645 -25	-0.4%	-$2.37K	0.01%	271
2017 Q3	$679K	Sell	6,670 -84,647	-93%	-$7.4M	0.02%	259
2017 Q2	$6.99M	Buy	91,317 +2,535	+3%	+$213K	0.18%	102
2017 Q1	$7.65M	Buy	88,782 +29,700	+50%	+$2.14M	0.2%	102
2016 Q4	$3.79M	Buy	59,082 +14,325	+32%	+$881K	0.11%	139
2016 Q3	$2.89M	Buy	44,757 +978	+2%	+$55.1K	0.08%	147
2016 Q2	$2.43M	Buy	+43,779	New	+$2.2M	0.07%	154

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Williams Jones & Associates's LKFT Position: Q2 2018 in Review

Williams Jones & Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2018, closing a stake of 6,645 shares — an estimated $663K sold.

Williams Jones & Associates first reported a position in LKFT in Q2 2016 and held it in 8 quarters. The position peaked at $7.65M in Q1 2017. 79 funds tracked by Wall St. Rank hold LKFT as of Q2 2018.

Williams Jones & Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2018 after selling out during the quarter.
Williams Jones & Associates sold 6,645 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2018, an estimated $663K.
Williams Jones & Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2016 and held it in 8 quarters.
Williams Jones & Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $7.65M in Q1 2017.
79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2018.

Based on Williams Jones & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.